What is the main reason for Pfizer's legal actions against Warner-Lambert and American Home Products?

Pfizer is taking legal action because it is attempting to acquire Warner-Lambert itself and views the proposed merger between Warner-Lambert and American Home Products as a direct obstacle to its own deal. The complaint specifically alleges a breach of a standstill agreement.

What is a 'standstill agreement' in this context?

A standstill agreement is a contract where one party agrees not to take certain actions, such as acquiring another company or initiating a proxy contest, for a specified period. Pfizer's allegation suggests that Warner-Lambert or American Home Products violated such an agreement, likely one that would have restricted their ability to pursue a merger without Pfizer's consent or at a time when Pfizer was also pursuing an acquisition.

What is the significance of the accelerated hearing by the Delaware Court of Chancery?

An accelerated hearing indicates that the court recognizes the urgency and potential significant impact of the matter, aiming to resolve Pfizer's request to block the merger more quickly. This suggests the court is giving serious consideration to Pfizer's legal arguments and the potential ramifications of the Warner-Lambert/AHP merger.

Does this filing provide specific financial projections or details of Pfizer's proposed merger with Warner-Lambert?

No, this Form 8-K filing primarily focuses on the legal and strategic maneuvers related to the proposed merger and the injunction against the Warner-Lambert/AHP deal. It incorporates press releases and a shareholder letter, but it does not contain detailed financial projections or the specifics of Pfizer's merger terms with Warner-Lambert itself.

PFE 8-K SEC Disclosure

Summary

This Form 8-K filing from Pfizer Inc. (PFE) dated December 1, 1999, primarily focuses on ongoing legal and strategic maneuvers related to the proposed merger between Warner-Lambert Company and American Home Products Corporation (AHP). Pfizer is actively seeking to enjoin this merger, asserting that it contravenes Pfizer's own proposed acquisition of Warner-Lambert. The report details Pfizer's legal actions, including a filed complaint alleging breach of a standstill agreement by Warner-Lambert and AHP, and highlights the court's decision to expedite a hearing on Pfizer's request to block the proposed Warner-Lambert/AHP transaction. Investors should note that this filing signals significant strategic contention in the pharmaceutical sector at the time. Pfizer's aggressive pursuit of Warner-Lambert and its efforts to disrupt the rival merger indicate a strong desire to acquire Warner-Lambert's assets and market presence. The accompanying exhibits, including press releases and a letter to shareholders, communicate Pfizer's position and strategy to stakeholders, emphasizing the company's commitment to its proposed deal and its legal recourse.

Key Highlights

1Pfizer is actively working to block the proposed merger between Warner-Lambert Company and American Home Products Corporation.
2The Delaware Court of Chancery has ordered an accelerated hearing regarding Pfizer's legal action to enjoin the Warner-Lambert/AHP merger.
3Pfizer has filed a complaint against Warner-Lambert and American Home Products, alleging a breach of a standstill agreement.
4The company published an advertisement on November 16, 1999, discussing its proposed merger with Warner-Lambert.
5A letter to shareholders from CEO William C. Steere, Jr., dated November 22, 1999, provides communication regarding the ongoing situation.
6This filing contains forward-looking statements that involve risks and uncertainties, and actual results could differ materially.

PFIZER INC 8-K Report (Dec 1, 1999)

Summary

Key Highlights

Frequently Asked Questions